News Archive

March 9, 2018 — Fueled by a multimillion dollar grant from the state’s stem cell agency, researchers at University of California San Diego School of Medicine, in collaboration with local biotechnology company Oncternal Therapeutics, have launched a phase Ib/II clinical trial to evaluate the combined effectiveness of a standard of care drug with a novel monoclonal antibody that target B-cell malignancies, which include leukemias and lymphomas.

March 8, 2018 — Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The findings, they say, represent an important proof-of-concept for the compound as there are currently no Food and Drug Administration-approved treatments for NAFLD and NASH.

March 7, 2018 — UC San Diego Health is the first hospital in California to use the fifth generation troponin test to diagnose heart attack. Approved in the United States in 2017, the more sensitive test can detect heart attack within an hour, as opposed to three to six hours.

March 5, 2018 — On March 12, 2018, UC San Diego Health will welcome its first patients to the Koman Family Outpatient Pavilion. Located on the La Jolla campus, the new 156,000-square-foot facility represents the most recent addition to the university’s world-class medical campus. In the past five years, UC San Diego Health has invested more than $1.3 billion dollars in patient care facilities for the community.

February 27, 2018 — Erik T. Mitchell, Ph.D. has been appointed university librarian at the University of California San Diego effective April 16, 2018. Mitchell currently serves as associate university librarian of Digital Initiatives and Collaborative Services and associate chief information officer at UC Berkeley.

February 20, 2018 — Presented together for the first time, seven internationally recognized artists are featured in the UC San Diego exhibition “Stories That We Tell: Art and Identity,” celebrating those who paved the way for greater inclusion by inventing new means to address issues of race and gender.

February 15, 2018 — Four early-career scientists at UC San Diego have been recognized for their outstanding promise in the fields of physics and computational & evolutionary molecular biology as 2018 Sloan Research Fellows.

February 15, 2018 — Party plans are underway at the University of California San Diego campus to celebrate the ingenious and creative spirit of Dr. Seuss during a noontime birthday bash on March 2, 2018. Festivities will include free cake, a giant, inflatable Cat in the Hat, and live entertainment by the Teeny Tiny Pit Orchestra.

February 13, 2018 — Armed with skill, special tools and light, University of California San Diego Associate Professor Neal Devaraj and a group of his chemistry graduate students activated cellular gene expression with unique precision. By modifying messenger RNA (mRNA)—a group of molecules that carries genetic information from DNA to ribosomes where specifications of gene expression occur—the chemists were able to precisely trigger gene expressions at a specific time and place using laser light. This novel technique will ease future studies of individual protein functions in cells or tissues at different stages of biological development.

February 13, 2018 — Philippe Sands has been dedicated to human rights issues throughout his career and has worked on high-profile human rights cases involving abuse. Now, in his book East West Street, Sands explores the creation and development of legal concepts that came about as a result of Hitler's Third Reich which changes our understanding of history and how civilization has tried to cope with mass murder.